Amgen, the world's largest biotech company by revenue, and deCODE, based in Reykjavik, Iceland, announced the all-cash deal Monday. DeCODE, founded in 1996, has discovered genetic risk factors for ...

Ten years after acquiring deCODE Genetics, Amgen’s collaboration with the Icelandic genetic sleuths has only blossomed, expanding from drug discovery to clinical development. The partners celebrated ...

Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the ...

Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer. In the results of a study published Nov. 6 in Nature ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes. Bipolar disorder is ...

The scientists at deCODE Genetics, a subsidiary of Amgen, sought to deepen the understanding of cis-acting influences of sequence variants on CpG methylation. In the study, the scientists were able to ...

REYKJAVIK, Islandia, 22 de enero de 2025 /PRNewswire/ -- Los científicos de deCODE genetics/Amgen han elaborado un mapa completo de cómo se mezcla el ADN humano a medida que se transmite durante la ...

For 25 years, Iceland’s deCODE Genetics has been one of the most powerful and prolific producers and analyzers of human genomic sequence data. Founded by neurologist Kári Stefánsson, deCODE has ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

Two men will lead deCODE genetics ehf -- Earl "Duke" Collier, past executive vice president at Genzyme and former deCODE board member, will serve as CEO, and deCODE's founder, Karl Stefansson, shifts ...

(AP) Biotech pioneer Amgen Inc., in a bid for a big edge in using people’s genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE ...